Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-25-332248
Filing Date
2025-12-29
Accepted
2025-12-29 09:31:58
Documents
3
Period of Report
2026-02-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A definitive_proxy_decembe.htm DEF 14A 571780
2 GRAPHIC img123237376_0.jpg GRAPHIC 134294
3 GRAPHIC img123237376_1.jpg GRAPHIC 86151
  Complete submission text file 0001193125-25-332248.txt   876824
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41934 | Film No.: 251604308
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)